U.S. Professional Services Stock News

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

Burford Capital recently reported that the US Court of Appeals for the Second Circuit reversed the prior District Court judgment in favor of Petersen and Eton Park in the long-running YPF litigation, prompting the company to review the case’s carrying value and consider a potentially material asset write-down in its upcoming first-quarter results. This reversal directly affects a case that represents a large share of Burford’s fair value assets, underscoring how concentrated legal exposures...

AnaptysBio has approved the spin off of First Tracks Biotherapeutics, with shareholders set to receive one First Tracks share for each AnaptysBio share held. First Tracks Biotherapeutics is expected to list on Nasdaq and will be funded through capital from AnaptysBio and a private placement. The company has added experienced industry executive Susannah Gray to its board as part of the transition. The spin off comes as AnaptysBio, listed as NasdaqGS:ANAB, is in focus with a current share...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with anticipated earnings growth of 15% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks with insider buying can offer unique opportunities for investors seeking potential value amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.9%, yet it has risen by 15% over the past year, with earnings forecast to grow annually by the same percentage. In this context of fluctuating short-term performance and promising long-term growth prospects, identifying high-growth tech stocks can be a strategic approach for investors looking to capitalize on innovation-driven sectors.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In such conditions, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets in a growing market.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In this environment, identifying growth companies with high insider ownership can be advantageous as they often signal confidence in long-term prospects and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 1.9%, while showing a notable 15% rise over the past year, with earnings expected to grow annually by the same percentage. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential becomes crucial for investors seeking stability and opportunity. Penny stocks, though an older term, still signify smaller or emerging companies that can offer significant value; when these companies have solid...

Icahn Enterprises (IEP) has drawn fresh attention after recent trading left the units at a last close of US$7.45, with returns mixed across recent periods and a value score of 4 catching investor interest. See our latest analysis for Icahn Enterprises. Recent trading has been soft, with a 1 day share price return of 2.74% and a 30 day share price return of 7.57%. The 1 year total shareholder return of 3.47% contrasts with a 3 year total shareholder return of 72.93% and a 5 year total...

The United States market has experienced a 1.9% decline over the last week, yet it remains up by 15% over the past year, with earnings projected to grow annually by 15%. In this dynamic environment, identifying stocks like Seneca Foods that offer unique value propositions and growth potential can be key to uncovering hidden opportunities.

Over the last 7 days, the United States market has experienced a 1.9% drop, although it has risen by 15% over the past year with earnings expected to grow annually by the same percentage. In this fluctuating environment, dividend stocks can offer stability and income potential for investors seeking consistent returns amidst market volatility.

Palo Alto Networks, Inc. ( NASDAQ:PANW ) shareholders (or potential shareholders) will be happy to see that the...

The Morning Bull - US Market Morning Update Monday, Mar, 30 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.5%, as investors weigh rising government bond yields against mixed signals on consumer confidence. The US 10 year yield sits near 4.4%, which means borrowing costs for mortgages, credit cards and companies remain relatively expensive. At the same time, the University of Michigan consumer sentiment index is revised down to 53.3, while...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regions Financial (NYSE:RF) has proposed amendments to its Certificate of Incorporation ahead of its upcoming annual meeting. The changes include eliminating certain supermajority voting provisions and removing specific business combination restrictions. The Board is also seeking to limit the liability of officers as permitted by Delaware law and introduce other governance updates. For investors watching NYSE:RF, these governance proposals come with the stock recently trading at $25.16...

Despite announcing strong earnings, GDS Holdings Limited's ( NASDAQ:GDS ) stock was sluggish. We think that the market...

OceanPal Inc. ( NASDAQ:SVRN ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

Why Tandem Diabetes Care (TNDM) Is Back On Investors’ Radar Tandem Diabetes Care (TNDM) has drawn attention after recent share price pressure, with the stock down about 10% over the past day, 16% over the past week, and 17% over the past month. See our latest analysis for Tandem Diabetes Care. That sharp 1 day share price return of about 10% and 30 day share price return of 17% come against a 1 year total shareholder return of 9.6%. However, the longer term total shareholder returns over 3...

How RBC Bearings' Valuation Stacks Up Against Its Market Price With RBC Bearings' share price around US$532.25, many investors are asking the same question: is the stock pricing in too much optimism, or are markets still underestimating its potential? Recent returns are mixed, with a 0.9% decline over the last 7 days and a 7.6% decline over the last 30 days, set against a 16.0% gain year to date and a 65.4% return over the past year. These moves sit in the context of RBC Bearings' longer term...

For investors considering whether Artivion at around US$35 per share still offers value or whether the recent run has already priced in the story, this article breaks down what the current market price might be implying. The stock has pulled back over the last week and month, with declines of 1.2% and 8.3%, respectively, while still sitting on a 43.6% return over 1 year and 176.1% over 3 years. Recent coverage has focused on Artivion's position in the medical equipment space and investor...

If you are wondering whether Bright Horizons Family Solutions at US$77.99 is priced attractively or asking too much for its prospects, the valuation picture is not as straightforward as the share price alone might suggest. The stock has seen a 4.7% gain over the past 30 days, but that sits against a 21.5% decline year to date and a 38.6% decline over the past year, which can shift how the market views both risk and potential reward. Recent coverage has focused on the company within the...